Report cover image

Asia-Pacific Transgenic Animal Model Market: Focus on Technology, Animal Type, Application, End User, and Country - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published May 26, 2026
Length 76 Pages
SKU # BIS21159075

Description

Market Overview

The APAC transgenic animal model market is witnessing significant growth, driven by expanding biotechnology research, increasing pharmaceutical R&D investments, and rising demand for advanced preclinical models. The global transgenic animal model market is expected to grow steadily during the forecast period 2025-2035, with Asia-Pacific emerging as a high-growth region. Countries such as China, Japan, and India are leading this expansion due to strong government support, growing research infrastructure, and increasing focus on genomics and personalized medicine. The region’s rapid adoption of gene-editing technologies and rising collaborations between academia and industry are further accelerating market growth.

The Asia-Pacific transgenic animal model market is projected to reach $1,698.4 million by 2035 from $660.2 million in 2025, growing at a CAGR of 9.91% during the forecast period 2025-2035.

Market Introduction

The APAC transgenic animal model market is becoming a key component of the region’s rapidly advancing life sciences and biotechnology ecosystem. Transgenic animal models are genetically engineered organisms that carry inserted or modified genes, enabling researchers to study gene function, disease progression, and therapeutic responses. These models are widely used in drug discovery, toxicology studies, and basic biological research.

In Asia-Pacific, the demand for transgenic animal models is increasing due to the growing burden of chronic diseases, rising investments in pharmaceutical and biotechnology sectors, and the expansion of research capabilities. Countries such as China and Japan are heavily investing in genomic research and gene-editing technologies, while India is emerging as a hub for contract research and preclinical studies.

Technological advancements, particularly in CRISPR/Cas9 gene-editing, have significantly improved the efficiency and accuracy of developing transgenic models, making them more accessible and cost-effective. Additionally, the increasing focus on precision medicine and targeted therapies is driving the need for highly specialized animal models that can replicate human disease conditions.

Regulatory frameworks across APAC are evolving to support ethical research practices, although variations exist across countries. As a result, the APAC transgenic animal model market is characterized by rapid innovation, growing investments, and increasing collaboration among stakeholders.

Market Segmentation:

Segmentation 1: By Technology

CRISPR/CAS-9
Microinjections
Embryonic Stem Cell Injections
Others

Segmentation 2: By Animal Type

Rodent (Mice & Rats)
Rabbits
Pigs
Others

Segmentation 3: By Application

Drug Discovery and Development
Disease Research
Gene Function Studies
Toxicology and Safety Testing
Others

Segmentation 4: By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)

Segmentation 5: by Country

China
Japan
India
South Korea
Australia
Rest-of-Asia-Pacific

Market Trends, Drivers, and Challenges

Market Trends

Rapid adoption of CRISPR/Cas9 and advanced gene-editing technologies
Increasing focus on precision medicine and targeted therapies
Expansion of transgenic models for oncology, neurology, and rare diseases
Growing collaborations between academic institutions and biotech companies

Market Drivers

Rising demand for efficient preclinical models in drug development
Increasing investments in biotechnology and life sciences research
Growing prevalence of chronic and genetic diseases in APAC
Expanding pharmaceutical and CRO industries in emerging economies

Market Challenges

Ethical concerns related to animal testing and genetic modification
High cost and technical complexity of developing transgenic models
Lack of standardized regulatory frameworks across APAC countries
Limitations in replicating complex human disease conditions

How This Report Can Add Value?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in transgenic animal model, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors’ strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new transgenic animal model products.

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 1-5 business days to complete the report upon order confirmation.

Table of Contents

76 Pages
Executive Summary
Scope and Definition
1 Asia-Pacific Transgenic Animal Model Market: Industry Outlook
1.1 Market Overview
1.1.1 Market Overview and Ecosystem
1.2 Market Trends
1.2.1 Impact Analysis
1.2.2 Rising Demand for Personalized Medicine
1.3 Regulatory Landscape
1.3.1 Asia-Pacific
1.3.1.1 China
1.3.1.2 Japan
1.4 Pricing Analysis
1.4.1 Generation Costs (Creating New Models)
1.4.2 Acquisition Costs (Purchasing Existing Models)
1.4.3 Additional Costs
1.5 Technology Landscape
1.6 Market Dynamics
1.6.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
1.6.2 Market Drivers
1.6.2.1 Growing Number of Pharmaceutical Research and Drug Development Activities
1.6.2.2 Technological Advancements in Genetic Engineering
1.6.2.3 Increasing Demand for Advanced Disease Models for Drug Discovery
1.6.3 Market Restraints
1.6.3.1 High Maintenance Cost of Animal Models
1.6.3.2 Strict Regulations and Guidelines
1.6.4 Market Opportunities
1.6.4.1 Emergence of CRISPR as a Powerful Tool for Biomedical Research Field
1.6.4.2 Increasing Demand for Disease-Specific Models
2 Region
2.1 Regional Summary
2.2 Asia Pacific
2.2.1 Regional Overview
2.2.2 Driving Factors for Market Growth
2.2.3 Factors Challenging the Market
2.2.4 Market Sizing and Forecast
2.2.4.1 Asia Pacific Transgenic Animal Model Market, by Technology
2.2.4.2 Asia Pacific Transgenic Animal Model Market, by Animal Type
2.2.4.3 Asia Pacific Transgenic Animal Model Market, by Application
2.2.4.4 Asia Pacific Transgenic Animal Model Market, by End User
2.2.4.5 Asia PacificTransgenic Animal Model Market, by Country
2.2.5 China
2.2.5.1 Country Overview
2.2.5.2 China Transgenic Animal Model Market, by Technology
2.2.5.3 China Transgenic Animal Model Market, by Animal Type
2.2.5.4 China Transgenic Animal Model Market, by Application
2.2.5.5 China Transgenic Animal Model Market, by End User
2.2.6 Japan
2.2.6.1 Country Overview
2.2.6.2 Japan Transgenic Animal Model Market, by Technology
2.2.6.3 Japan Transgenic Animal Model Market, by Animal Type
2.2.6.4 Japan Transgenic Animal Model Market, by Application
2.2.6.5 Japan Transgenic Animal Model Market, by End User
2.2.7 India
2.2.7.1 Country Overview
2.2.7.2 India Transgenic Animal Model Market, by Technology
2.2.7.3 India Transgenic Animal Model Market, by Animal Type
2.2.7.4 India Transgenic Animal Model Market, by Application
2.2.7.5 India Transgenic Animal Model Market, by End User
2.2.8 Australia
2.2.8.1 Country Overview
2.2.8.2 Australia Transgenic Animal Model Market, by Technology
2.2.8.3 Australia Transgenic Animal Model Market, by Animal Type
2.2.8.4 Australia Transgenic Animal Model Market, by Application
2.2.8.5 Australia Transgenic Animal Model Market, by End User
2.2.9 South Korea
2.2.9.1 Country Overview
2.2.9.2 South Korea Transgenic Animal Model Market, by Technology
2.2.9.3 South Korea Transgenic Animal Model Market, by Animal Type
2.2.9.4 South Korea Transgenic Animal Model Market, by Application
2.2.9.5 South Korea Transgenic Animal Model Market, by End User
2.2.10 Rest-of-the- Asia Pacific
2.2.10.1 Country Overview
2.2.10.2 Rest of the Asia Pacific Transgenic Animal Model Market, by Technology
2.2.10.3 Rest of the Asia Pacific Transgenic Animal Model Market, by Animal Type
2.2.10.4 Rest of the Asia Pacific Transgenic Animal Model Market, by Application
2.2.10.5 Rest of the Asia Pacific Transgenic Animal Model Market, by End User
3 Competitive Benchmarking and Company Profiles
3.1 Company Profiles
3.1.1 HuidaGene
3.1.1.1 Overview
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Inclusion and Exclusion
4.1.4 Data Triangulation
4.2 Market Estimation and Forecast
List of Figures
Figure 1: Asia-Pacific Transgenic Animal Model Market (by Scenario), $Million, 2024, 2028, and 2035
Figure 2: Asia-Pacific Transgenic Animal Model Market, 2024 and 2035
Figure 3: Asia-Pacific Transgenic Animal Model Market Snapshot
Figure 4: Transgenic Animal Model Market, $Million, 2024 and 2035
Figure 5: Asia-Pacific Transgenic Animal Model Market (by Technology), $Million, 2024, 2028, and 2035
Figure 6: Asia-Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024, 2028, and 2035
Figure 7: Asia-Pacific Transgenic Animal Model Market (by Application), $Million, 2024, 2028, and 2035
Figure 8: Asia-Pacific Transgenic Animal Model Market (by End User), $Million, 2024, 2028, and 2035
Figure 9: Key Stakeholders of Transgenic Animal Model Market
Figure 10: Transgenic Animals: Timeline of Key Events
Figure 11: Role of Humanized Mouse Models in Development of New Precision and Personalized Medicine Strategies
Figure 12: Evolution of Transgenic Technologies
Figure 13: Drug Development Pipeline, 2019 and 2024
Figure 14: Major Technical Advances in Genome Editing and Delivery in Mice and Rats from 1980s to 2020s
Figure 15: Asia Pacific Transgenic Animal Model Market, $Million, 2024-2035
Figure 16: Inclusion and Exclusion Criteria for Transgenic Animal Model Market
Figure 17: Data Triangulation
Figure 18: Top-Down and Bottom-Up Approach
Figure 19: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Cost of Generating New Transgenic Animals
Table 3: Cost of Purchasing Existing Models
Table 4: Additional Costs
Table 5: Transgenic Animal Model Market (by Region), $Million, 2024-2035
Table 6: Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 7: Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 8: Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 9: Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 10: Asia Pacific Transgenic Animal Model Market (by Country), $Million, 2024-2035
Table 11: China Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 12: China Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 13: China Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 14: China Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 15: Japan Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 16: Japan Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 17: Japan Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 18: Japan Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 19: India Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 20: India Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 21: India Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 22: India Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 23: Australia Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 24: Australia Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 25: Australia Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 26: Australia Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 27: South Korea Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 28: South Korea Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 29: South Korea Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 30: South Korea Transgenic Animal Model Market (by End User), $Million, 2024-2035
Table 31: Rest of the Asia Pacific Transgenic Animal Model Market (by Technology), $Million, 2024-2035
Table 32: Rest of the Asia Pacific Transgenic Animal Model Market (by Animal Type), $Million, 2024-2035
Table 33: Rest of the Asia Pacific Transgenic Animal Model Market (by Application), $Million, 2024-2035
Table 34: Rest of the Asia Pacific Transgenic Animal Model Market (by End User), $Million, 2024-2035

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us